Twenty expensive new medicines are expected to go to cabinet for approval this year, the Department of Health has said.
Under a radically changed approval process, the government now has to approve expensive medicines before the Health Service Executive (HSE) will pay for them.
New drugs to treat cancer, high cholesterol and cystic fibrosis are at various stages of the assessment process at present. The cumulative cost of these medicines is about €300 million per...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Team Pass
Get a Business Account for you and your team